The estimated Net Worth of Donald A Lucas is at least $239 Thousand dollars as of 5 September 2019. Mr. Lucas owns over 4,602 units of Avinger Inc stock worth over $5,406 and over the last 20 years he sold AVGR stock worth over $233,759. In addition, he makes $0 as Independent Director at Avinger Inc.
Donald has made over 5 trades of the Avinger Inc stock since 2005, according to the Form 4 filled with the SEC. Most recently he exercised 4,602 units of AVGR stock worth $5,338 on 5 September 2019.
The largest trade he's ever made was selling 9,309 units of Avinger Inc stock on 6 May 2016 worth over $117,107. On average, Donald trades about 629 units every 120 days since 2005. As of 5 September 2019 he still owns at least 4,660 units of Avinger Inc stock.
You can see the complete history of Mr. Lucas stock trades at the bottom of the page.
Donald A. Lucas Jr. serves as Independent Director of the Company. has served as a member of our board of directors since 2013 and has been an investor in our company since 2011. Mr. Lucas has been a venture capitalist since 1985, having invested in companies such as Oracle, Macromedia and Cadence Design alongside his father Donald L. Lucas. Mr. Lucas has sourced or led investments in companies such as Intuitive Surgical, Coulter Pharmaceutical, Dexcom, Infinera, Signifyd, Obalon Therapeutics, Katerra, Bossa Nova Robotics, Filld, Berkeley Lights Inc, and Palantir. Mr. Lucas has served on the boards of Dexcom and the Silicon Valley Chapter of the JDRF and is a member of the UCSF Diabetes Center Leadership Council. Mr. Lucas serves on the advisory board for U.S. Bank. Mr. Lucas holds a B.A. from Santa Clara University.
Donald Lucas is 56, he's been the Independent Director of Avinger Inc since 2013. There are 6 older and 3 younger executives at Avinger Inc. The oldest executive at Avinger Inc is James Cullen, 77, who is the Independent Chairman of the Board.
Donald's mailing address filed with the SEC is 400, Chesapeake Drive, Redwood City, San Mateo County, California, 94063, United States.
Over the last 10 years, insiders at Avinger Inc have traded over $4,931,811 worth of Avinger Inc stock and bought 65,650 units worth $291,405 . The most active insiders traders include John B Ph D Md Simpson, James Cullen, and Jeffrey M Soinski. On average, Avinger Inc executives and independent directors trade stock every 57 days with the average trade being worth of $43,246. The most recent stock trade was executed by Nabeel Paul Subainati on 22 March 2023, trading 417 units of AVGR stock currently worth $484.
avinger, inc. is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems for the treatment of patients with peripheral artery disease (pad). pad is characterized by a build-up of plaque in the arteries that supply blood to the arms and legs. the company’s mission is to radically change the way vascular disease is treated through the introduction of products based on its lumivascular platform, the only intravascular image-guided system of therapeutic catheters available in this market. avinger’s current lumivascular products include the lightbox imaging console, the ocelot family of catheters, which are designed to penetrate total arterial blockages, known as chronic total occlusions, or ctos, and pantheris, the first-ever image- guided atherectomy device, designed to precisely remove arterial plaque in pad patients.
Avinger Inc executives and other stock owners filed with the SEC include: